Tuesday, December 4, 2012

Medical News

Medical News


Bipolar disorder prevalent in panic disorder patients

Posted: 04 Dec 2012 04:00 PM PST

Bipolar disorder is common among Japanese patients with panic disorder, research shows.

Depression, anxiety not linked to psychosis transition

Posted: 04 Dec 2012 04:00 PM PST

Depression and anxiety disorders are common in patients at increased clinical risk for psychosis, but do not appear to influence transition to full-blown psychosis, say UK researchers.

Bipolar disorder prevalent in panic disorder patients

Posted: 04 Dec 2012 04:00 PM PST

Bipolar disorder is common among Japanese patients with panic disorder, research shows.

Depression, anxiety not linked to psychosis transition

Posted: 04 Dec 2012 04:00 PM PST

Depression and anxiety disorders are common in patients at increased clinical risk for psychosis, but do not appear to influence transition to full-blown psychosis, say UK researchers.

Intervention helps postmenopausal women relax

Posted: 03 Dec 2012 04:00 PM PST

Applied relaxation techniques could help postmenopausal women significantly reduce the number of hot flashes they experience each day, research suggests.

Websites offering 'designer vaginas' lack information

Posted: 03 Dec 2012 04:00 PM PST

Websites for providers offering female genital cosmetic surgery contain poor quality and limited clinical information regarding procedures and risks, show study results.

Sputum color guides antibiotic treatment in COPD

Posted: 03 Dec 2012 04:00 PM PST

Withholding antibiotic treatment from hospitalized chronic obstructive lung disease patients with nonpurulent sputum does not negatively affect outcomes, a pilot study shows.

Novel device improves post-prostatectomy incontinence

Posted: 02 Dec 2012 04:00 PM PST

Researchers have developed a novel device that improves stress urinary incontinence in men who have undergone prostatectomy, report researchers.

Dutasteride delays PSA progression

Posted: 27 Nov 2012 04:00 PM PST

The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.

No comments:

Post a Comment